Retinoid-induced histone deacetylation inhibits telomerase activity in estrogen receptor-negative breast cancer cells

Anticancer Research

Volumn 29, Issue 12, 2009, Pages 4959-4964

  Phipps, Sharla M O ^a   Love, William K ^a   White, Teresa ^a   Andrews, Lucy G ^a   Tollefsbol, Trygve O ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Breast cancer; Epigenetic; Histone deacetylation; hTERT; Retinoic acid; Telomerase

Indexed keywords

ESTROGEN RECEPTOR; HISTONE H3; LYSINE; RETINOIC ACID; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DEACETYLATION; DNA METHYLATION; DRUG EFFECT; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SOMATIC CELL;

ACETYLATION; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL ADHESION; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; FEMALE; HISTONES; HUMANS; PROMOTER REGIONS, GENETIC; RECEPTORS, ESTROGEN; TELOMERASE; TRANSCRIPTION, GENETIC; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 75149127233     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Yang L, Tin-U C, Wu L and Brown P: Role of retinoid receptors in the prevention and treatment of breast cancer. J Mammary Gland Biol Neoplasia 4: 377-388, 1999.
2. Roman S, Clarke C, Hall R, Alexander I and Sutherland R: Expression and regulation of retinoic acid receptors in human breast cancer cells. Cancer Res 52: 2236-2242, 1992.
3. van der Burg B, van der Leede BM, Kwakkenbos-Isbrucker L, Salverda S, de Laat SW and van der Saag PT: Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function. Mol Cell Endocrinol 91: 149-157, 1993.
4. Hansen NJ, Wylie RC, Phipps SM, Love WK, Andrews LG and Tollefsbol TO: The low-toxicity 9-cis UAB30 novel retinoid down-regulates the DNA methyltransferases and has anti-telomerase activity in human breast cancer cells. Int J Oncol 30: 641-650, 2007.
5. Krupitza G, Huila W, Harant H, Dittrich E, Kallay E, Huber H, Grunt T and Dittrich C. Retinoic acid induced death of ovarian carcinoma cells correlates with c-myc stimulation. Int J Cancer 61: 649-657, 1995.
6. Love WK, Berletch JB, Andrews LG and Tollefsbol TO: Epigenetic regulation of telomerase in retinoid-induced differentiation of human leukemia cells. Int J Oncol 32: 625-631, 2008.
7. Fitzgerald P, Teng M, Chandraratna RA, Heyman RA and Allegretto EA: Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status. Cancer Res 57: 2642-2650, 1997.
8. Liu L, Saldanha SN, Pate MS, Andrews LG and Tollefsbol TO: Epigenetic regulation of human telomerase reverse transcriptase promoter activity during cellular differentiation. Genes Chromosomes Cancer 41: 26-37, 2004.
9. Jenuwein T and Allis CD: Translating the histone code. Science 293: 1074-1080, 2001.
10. Casillas MA, Lopatina N, Andrews LG and Tollefsbol TO: Transcriptional control of the DNA methyltransferases is altered in aging and neoplastically-transformed human fibroblasts. Mol Cell Biochem 252: 33-43, 2003.
11. Schneider SM, Offterdinger M, Huber H and Grunt TW: Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells. Cancer Res 60: 5479-5487, 2000.
12. Guilleret I, Yan P, Grange R, Braunschweig R, Bosman FT and Benhattar J: Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity. Int J Cancer 101: 335-341, 2002.
13. Renaud S, Loukinov D, Abdullaev Z, Guilleret I, Bosman FT Lobanenkov V and Benhattar J: Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene. Nucleic Acids Res 35: 1245-1256, 2007.
14. Zinn RL, Pruitt K, Eguchi S, Baylin SB and Herman JG: hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site. Cancer Res 67: 194-201, 2007.